Bausch Health Companies (BHC) Free Cash Flow (QoQ) (2009 - 2026)
Bausch Health Companies (BHC) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.70 Bn | 384.24 Mn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.98% |
| Dec 31, 2025 | 28.34% |
| Sep 30, 2025 | 65.26% |
| Jun 30, 2025 | 97.92% |
| Mar 31, 2025 | -80.61% |
| Dec 31, 2024 | 48.20% |
| Sep 30, 2024 | 10.60% |
| Jun 30, 2024 | 134.11% |
| Mar 31, 2024 | -55.82% |
| Dec 31, 2023 | 21.67% |
| Sep 30, 2023 | 34.83% |
| Jun 30, 2023 | 66.36% |
| Mar 31, 2023 | -73.84% |
| Dec 31, 2022 | 131.06% |
| Sep 30, 2022 | -1,954.93% |
| Jun 30, 2022 | 165.14% |
| Mar 31, 2022 | -101.85% |
| Dec 31, 2021 | -110.78% |
| Sep 30, 2021 | 50.45% |
| Jun 30, 2021 | -11.67% |